Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arylsulfatase H (ARSH) is a member of the sulfatase enzyme family, specifically classified as an arylsulfatase, which catalyzes the hydrolysis of sulfate esters from a diverse array of substrates including sulfated steroids, carbohydrates, proteoglycans, and glycolipids[5]. Sulfatase enzymes play crucial roles in regulating hormone metabolism, carbohydrate catabolism, and the degradation of complex molecules involved in cellular and developmental signaling. ARSH, like other sulfatases, is functionally important in lysosomal metabolism, participating in the breakdown of sulfated compounds to maintain cellular homeostasis. While other sulfatases such as arylsulfatase A (ARSA) are directly linked to inherited lysosomal storage diseases, there are currently no well-established disease linkages or clinical biomarker applications described specifically for ARSH. ARSH is considered a therapeutic target due to its classified role as a lysosomal enzyme, but as of now, there are no drugs known to target ARSH directly[5].
Catalytic hydrolysis of sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arylsulfatase H (ARSH).